Keywords
Aluminum chloride
Phytocannabinoids
Delta-9-tetrahydrocannabinol (THC): Cannabidiol (CBD)
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To evaluate the therapeutic potential of Cannabis sp extract in a model of Alzheimer's disease induced by aluminum chloride in rats. Methods: Thirty Wistar rats were divided into five groups (n=6) where one group received no treatment, another group received only aluminum chloride and the others, in addition to aluminum chloride, received different doses (50, 100 and 150µl) of oily extract of Cannabis sp. The animals were euthanized one day after treatment, where the brain was collected, fixed, processed and embedded in paraffin. Histological sections of the hippocampus were used for qualitative and quantitative assessment of morphological changes. Blood serum was also obtained to determine indicators of oxidative status. Results: Reduction of more than 80% in cell death in the dentate gyrus region of the hippocampus in animals treated with cannabis extract. Furthermore, a reduction in total protein levels by approximately 20% and an increase (15%) in antioxidant enzymes in relation to the positive control were also observed in the serum. Conclusion: The use of the oily extract of Cannabis sp. in a 2:1 ratio of delta-9-tetrahydrocannabinol (THC): Cannabidiol (CBD) effectively reduced hippocampal neuron deaths from amyloidosis induced in chronic aluminum chloride intoxication.
References
AHANGARPOUR A, et al. Effects of hydro-alcoholic extract from arctium lappa l. (burdock) root on gonadotropins, testosterone, and sperm count and viability in male mice with nicotinamide/ streptozotocin-induced type 2 diabetes. Malaysian Journal of Medical Sciences, 2015; 22: 25–32.
AKBAR M, et al. Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress. Brain Research, 2016; 1637: 34–55.
AL-OKBI SY, et al. Evaluation of plant food extracts in experimental model of Alzheimer’s like disease induced by aluminum lactate in rats. Journal of Applied Pharmaceutical Science, 2017; 7: 070–076.
AUTI ST and KULKARNI YA. Neuroprotective effect of cardamom oil against aluminum induced neurotoxicity in rats. Frontiers in Neurology, 2019; 10: 1–17.
BLAISE GA, et al. Nitric oxide, cell signaling and cell death. Toxicology, 2005; 208: 177–192.
CAO C, et al. The potential therapeutic effects of THC on Alzheimer’s disease. Journal of Alzheimer’s Disease, 2014; 42: 973–984.
CASAREJOS MJ, et a. Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy. Journal of Alzheimer’s Disease, 2013; 35: 525–539.
COSTA B, et al. The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain. European Journal of Pharmacology, 2007; 556: 75–83.
DRYBURGH LM, et al. Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects. British Journal of Clinical Pharmacology, 2018; 84: 2468–2476.
ENGLUND A, et al. Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. Journal of Psychopharmacology, 2013; 27: 19–27.
ESPOSITO G, et al. Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in β-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-κB involvement. Neuroscience Letters, 2006; 399: 91–95.
GHUMATKAR PJ, et al. Nootropic, neuroprotective and neurotrophic effects of phloretin in scopolamine induced amnesia in mice. Pharmacology Biochemistry and Behavior, 2015; 135: 182–191.
HANUŠ LO and HOD Y. Terpenes/Terpenoids in Cannabis: Are They Important? Medical Cannabis and Cannabinoids, 2020; 3: 61–73.
Hao F, Feng Y. Cannabidiol (CBD) enhanced the hippocampal immune response and autophagy of APP/PS1 Alzheimer’s mice uncovered by RNA-seq. Life Sciences, 2021; 264.
IUVONE T, et al. Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on β-amyloid-induced toxicity in PC12 cells. Journal of Neurochemistry, 2004; 89: 134–141.
KOPUSTINSKIENE DM, et al. Bioactive Compounds and Their Protective Role in Oxidative Stress and Inflammation. Antioxidants, 2022; 11: 660.
LAKSHMI BVS, et al. Protective Effect of Selenium Against Aluminum Chloride-Induced Alzheimer’s Disease: Behavioral and Biochemical Alterations in Rats. Biological Trace Element Research, 2015; 165: 67–74.
LOERA-VALENCIA R, et al. Current and emerging avenues for Alzheimer’s disease drug targets. Journal of Internal Medicine, 2019; 286: 398–437.
LOWRY OH, et al. Protein measurement with the folin phenol reagent. Analytical Biochemistry, 1951;193: 265–275.
MARKESBERY WR. Oxidative stress hypothesis in Alzheimer’s disease. Free Radical Biology and medicine, 1997; 23: 134–147.
MARTÍN-MORENO AM, et al. Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice. Journal of Neuroinflammation, 2012; 9: 8.
MC V, et al. Immunochemical and morphometric features of astrocyte reactivity vs. plaque location in Alzheimer’s disease. Medicina (B Aires), 2005; 213–218.
OBERHOLZER M, et al. Methods in quantitative image analysis. Histochemistry and cell biology, 1996; 105: 333–355.
OHYAGI Y, MIYOSHI K. Aluminum and Alzheimer’s Disease: An Update. Alzheimer’s Disease & Parkinsonism, 2013; 3: 01–07.
OZCANKAYA R, Delibas N. Malondialdehyde, superoxide dismutase, melatonin, iron, copper, and zinc blood concentrations in patients with Alzheimer disease: Cross-sectional study. Croatian Medical Journal, 2002; 43: 28–32.